SR ONE CAPITAL MANAGEMENT, LLC

10% owner at Zenas BioPharma, Inc. · on record since Sep 16, 2024
10% owner at Avalyn Pharma Inc. · on record since Apr 29, 2026
10% owner at Odyssey Therapeutics, Inc. · on record since May 7, 2026
10% owner at Design Therapeutics, Inc. · on record since Mar 30, 2021
10% owner at eFFECTOR Therapeutics, Inc. · on record since Sep 2, 2021
10% owner at Arcellx, Inc. · on record since Feb 10, 2022
10% owner at ADARx Pharmaceuticals, Inc. · on record since Sep 24, 2026

Insider trading activity of SR ONE CAPITAL MANAGEMENT, LLC

Transactions on record: 77; since Apr 1, 2021

Open-market buys: 14; $92.6M

Open-market sells: 3; $32K

Companies traded: 5; last filing Sep 29, 2026

Figures computed from official regulatory filings — .

Companies where SR ONE CAPITAL MANAGEMENT, LLC has traded

ADARx Pharmaceuticals, Inc.15 tx · $27.2M · Sep 29, 2026
Odyssey Therapeutics, Inc.36 tx · $10M · May 11, 2026
Avalyn Pharma Inc.10 tx · $10M · May 1, 2026
Zenas BioPharma, Inc.11 tx · $40.4M · Oct 14, 2025
Design Therapeutics, Inc.5 tx · $5M · Apr 1, 2021

Track record of SR ONE CAPITAL MANAGEMENT, LLC

Statistical track record

Free account

Open-market buys: 14

Last buy: Sep 28, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of SR ONE CAPITAL MANAGEMENT, LLC

Co-insiders of SR ONE CAPITAL MANAGEMENT, LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-1,953,773	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-1,304,883	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Buy	592,593	17.00 USD	$10.1M	conv 54Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-3,907,547	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Buy	414,814	17.00 USD	$7.1M	conv 46Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-600,962	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	1,113,666	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-198,019	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	1,667,468	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Buy	592,593	17.00 USD	$10.1M	conv 46Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	512,897	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	169,001	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	1,538,691	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-1,802,885	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	3,334,938	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	Other	204,658	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-764,312	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-6,644,650	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-600,142	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-1,614,650	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	Other	463,106	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	Other	139,366	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	Other	78,656	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-1,299,842	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-4,606,320	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-1,953,773	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-1,304,883	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Buy	592,593	17.00 USD	$10.1M	conv 54Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-3,907,547	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Buy	414,814	17.00 USD	$7.1M	conv 46Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-600,962	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	1,113,666	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-198,019	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	1,667,468	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Buy	592,593	17.00 USD	$10.1M	conv 46Cluster	SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	512,897	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	169,001	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	1,538,691	—	n/a (No price was disclosed in the filing)		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	OtherD (derivative)	-1,802,885	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ADARx Pharmaceuticals, Inc.Listing unverified	Sep 29, 2026	Other	3,334,938	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	Other	204,658	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-764,312	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-6,644,650	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-600,142	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-1,614,650	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	Other	463,106	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	Other	139,366	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	Other	78,656	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-1,299,842	—	n/a (No price was disclosed in the filing)		SEC
Odyssey Therapeutics, Inc.Listing unverified	May 11, 2026	OtherD (derivative)	-4,606,320	—	n/a (No price was disclosed in the filing)		SEC